(E) | 1. |
下列疾病與目前已知有效之治療藥物的配對,何者是錯誤的?
|
A. | Multiple myeloma: Lenalidomide |
B. | Chronic myeloid leukemia: Dasatinib |
C. | Diffuse large B-cell lymphoma: Rituximab |
D. | Paroxysmal nocturnal hemoglobinuria: Eculizumab |
E. | Polycythemia vera: Prednisolone |
|
(B) | 2. |
一位72歲病人因為出血傾向及疲倦應診,抽血檢查顯示血紅素為8.2 g/dL,白血球24000/uL,血小板12000/uL;血液抹片如圖所示。這位病人最可能得了何種病?
|
A. | Chronic myeloid leukemia |
B. | Chronic myelomonocytic leukemia |
C. | Chronic lymphocytic leukemia |
D. | Acute myeloid leukemia |
E. | Acute lymphoblastic leukemia (ALL) |
|
(D) | 3. |
一位23歲病人因呼吸急促應診,血液檢查顯示血紅素為6.3 g/dL,血小板、白血球及分類正常,網狀紅血球(reticulocyte) 3.5%,全膽紅素 (total bilirubin) 3.4 mg/dL,直接膽紅素 (direct bilirubim) 0.7 mg/dL;血液抹片如圖所示。此位病人最可能得了什麼病?
|
A. | Iron deficiency anemia |
B. | Autoimmune hemolytic anemia |
C. | Vit B12 deficiency anemia |
D. | Thalassemia |
E. | G6PD deficiency |
|
(A) | 4. |
標靶治療藥物Tyrosine kinase inhibitor, Imatinib, 對下列何種急性淋巴芽細胞白血病(ALL)有效?
|
A. | B-lineage ALL with t(9;22) |
B. | B-lineage ALL with t(4;11) |
C. | CD19 positive B-lineage ALL |
D. | CD20 positive B-lineage ALL |
E. | CD3 positive T-lineage ALL |
|
(D) | 5. |
Eltrombopag目前為健保給付治療免疫性血小板低下性紫斑症(immune thrombocytopenic purpura)的第二線用藥,它的作用機轉為何?
|
A. | Anabolic hormone |
B. | Corticosteroid |
C. | Immunosuppressive agent |
D. | Thrombopoietin receptor agonist |
E. | JAK inhibitor |
|
(E) | 6. |
一位病人因血小板低下應診,下列各項檢驗中何者為鑑別血小板低下原因幫忙最小者?
|
A. | H. pylori infection |
B. | Serology tests for SLE |
C. | Hepatitis C infection |
D. | HIV infection |
E. | Platelet antibodies |
|
(D) | 7. |
對於多發性骨髓瘤(multipel myeloma)的診斷及分期,下列何項檢查是最不需要者?
|
A. | Immunoelectrophoresis |
B. | Albumin level |
C. | Beta 2-microglobulin level |
D. | Bone scan |
E. | Plain bone radiography |
|
(A) | 8. |
一位40歲病人抱怨胃痛,內視鏡檢查發現胃竇(gastric antrum)有一腫瘤,病理切片檢查顯示為mucosa-associated lymphoid tissue lymphoma,CD20陽性及H. pylori陽性,分期檢查未發現其他異常。下列何者為此病人最適當的第一線治療?
|
A. | Eradication of H. pylori |
B. | Rituximab |
C. | Chemotherapy |
D. | Rituximab + Chemotherapy |
E. | Local irradiation |
|
(D) | 9. |
下列何種狀況常會出現prothrombin time (PT)正常但activated partial thromoplostim time (aPTT)延常的現象?(1) Hepatic failure;(2) Antiphospholipid syndrome;(3) von Willebrand disease;(4) Disseminated intravascular coagulation
|
A. | (1)+(4) |
B. | (2)+(4) |
C. | (1)+(2) |
D. | (2)+(3) |
E. | (1)+(2)+(4) |
|
(B) | 10. |
下列何者是B細胞慢性淋巴性白血病(chronic lymphocytic leukemia)細胞的特徵,可與反應性淋巴細胞過多症做鑑別診斷?(1) Monoclonal light chain restriction;(2) CD5 expression;(3) CD10 expression
|
A. | (1) |
B. | (1)+(2) |
C. | (1)+(3) |
D. | (2)+(3) |
E. | (1)+(2)+(3) |
|